4
Changes in Ownership
HAEMONETICS CORP Filed Acc 0001127602-24-016162
EVP, Chief Financial Officer acquired 4,439 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DArecca James EVP, Chief Financial Officer | 2024-05-17 | Grant or award | +4,439 | 17,346 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DArecca James EVP, Chief Financial Officer | 2024-05-17 | Grant or award · Non-qualified Stock Option (Right to Buy) | +9,756 | 9,756 | D: show line 2 in the form |
Loading xslF345X05/form4.xml…